The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,10-diphenylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione ID: ALA471512
PubChem CID: 13161703
Max Phase: Preclinical
Molecular Formula: C23H15N3O2
Molecular Weight: 365.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1nc2n(-c3ccccc3)c3ccccc3cc-2c(=O)n1-c1ccccc1
Standard InChI: InChI=1S/C23H15N3O2/c27-22-19-15-16-9-7-8-14-20(16)25(17-10-3-1-4-11-17)21(19)24-23(28)26(22)18-12-5-2-6-13-18/h1-15H
Standard InChI Key: QZMFJFGKPYILFG-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
16.3768 -13.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0929 -12.8761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0900 -12.0459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3750 -11.6369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6622 -12.8766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6664 -12.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9562 -11.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9479 -13.2888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2330 -12.8694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2337 -12.0389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5188 -11.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7987 -12.0378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7980 -12.8683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5175 -13.2863 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0831 -13.2793 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5206 -10.8008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9449 -14.1135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0854 -11.6238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0924 -10.8015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3799 -10.3876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6639 -10.7985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6647 -11.6274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3777 -12.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2284 -14.5197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2251 -15.3436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9384 -15.7595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6565 -15.3452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6563 -14.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
5 8 1 0
11 16 2 0
6 7 1 0
8 17 1 0
7 10 2 0
12 18 1 0
9 8 1 0
18 19 2 0
9 10 1 0
19 20 1 0
3 4 2 0
20 21 2 0
4 6 1 0
21 22 1 0
5 6 2 0
22 23 2 0
23 18 1 0
1 2 2 0
17 24 2 0
5 1 1 0
24 25 1 0
2 3 1 0
25 26 2 0
9 14 2 0
26 27 1 0
10 11 1 0
27 28 2 0
28 17 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.39Molecular Weight (Monoisotopic): 365.1164AlogP: 3.64#Rotatable Bonds: 2Polar Surface Area: 56.89Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.08CX LogP: 4.17CX LogD: 4.17Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.45Np Likeness Score: -0.64
References 1. Ali HI, Tomita K, Akaho E, Kunishima M, Kawashima Y, Yamagishi T, Ikeya H, Nagamatsu T.. (2008) Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase., 43 (7): [PMID:18055068 ] [10.1016/j.ejmech.2007.10.011 ]